 |
|
|
| |
A Retrospective Study to Evaluate the Effect of Switching Antiretroviral Therapy to a Fixed-Dose Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate in HIV Infected Patients With Suppressed Viral Load In a Clinical Setting - The Switch to Complera (TSC) Study
|
| |
| |
Reported by Jules Levin
IDSA Oct 8-12 2014 Philadelphia
ANA MONCZOR, MD1, XIAOYING YU, MD, MS2, KAREN J. VIGIL, MD3, CLAUDIA KOZINETZ, PHD, MPH2 and ROBERTO ARDUINO, MD3
1FUNCEI - Fundación Centro de Estudios Infectológicos, Buenos Aires, Argentina, 2Baylor College of Medicine and Study Design and Analysis Core, Baylor-UTHouston Center for AIDS Research, Houston, TX, 3UTHealth, Houston, TX.
IDSA: Switch to Complera in Clinical Practice Usually Safe and Effective - Mark Mascolini - (10/24/14)
|
| |
|
|
|
|
|
